What is the Impact Factor of Current Oncology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Current Oncology is 3.60, ranking in quartile Q2 of Web of Science (SCIE).

Is Current Oncology indexed in Web of Science or Scopus?

Yes, Current Oncology is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.132 (Q2) and an H-index of 84.

Who publishes Current Oncology and what is the Article Processing Charge (APC)?

Current Oncology is published by Multimed Inc.. The estimated Article Processing Charge (APC) is approximately $3,300 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Current Oncology?

The official ISO-4 abbreviation of Current Oncology is "CURR ONCOL". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #3,997Hybrid

Current Oncology

Abbreviation (ISO):CURR ONCOL

•

Identifier (ISSN):1198-0052(Print)/1718-7729(Online)

•

Publisher:Multimed Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

3.6↑ +0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Current Oncology

WoS Q2

Annual Impact Factor Metric

Current (2026):3.6

Scopus SJR & RankScopus Q2

1.132

#3,997

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

84 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate7.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

437articles/year

99.9% Gold OA•77.27% Original Research

Aims & Scope

Current Oncology is a peer-reviewed, Canadian-based and internationally respected journal. Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy in Canada to report upon and to review progress in the management of this disease. We encourage submissions from all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.

Topics Covered (Recognized by AI)

Medicine99.6%Biology89.4%Internal medicine88.1%Genetics79.6%Cancer68.8%Pathology64.9%Surgery53.5%Oncology47.1%Radiology29%Chemistry28.2%Mathematics28%Psychology27.3%Statistics23.8%Biochemistry23.7%Sociology22.8%Political science22.4%Law22.1%Immunology21.9%Family medicine20.9%Breast cancer20.6%Chemotherapy20.2%

Primary Research Areas

Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank132/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank174/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	132/333	Q2
ONCOLOGY	JCISCIE	174/333	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.6

Articles / Year531

Total Citations162

2025

IF3.4

Articles / Year711

Total Citations2,108

2024

IF2.8

Articles / Year607

Total Citations3,968

2023

IF2.6

Articles / Year741

Total Citations9,225

2022

IF3.109

Articles / Year813

Total Citations13,050

Year	Impact Factor	Articles / Year	Total Citations
2026	3.6	531	162
2025	3.4	711	2,108
2024	2.8	607	3,968
2023	2.6	741	9,225
2022	3.109	813	13,050
2021	3.677	445	7,392
2020	2.257	194	3,662
2019	1.862	178	3,538
2018	1.967	155	4,873
2017	—	141	2,743
2016	—	168	3,326
2015	—	149	3,286

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,997Scopus Q2SCImago Profile

Scopus Coverage:1998-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

1.132

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

3.64

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,300 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations8,352

3-Year Documents2,144

Citable Documents2,087

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate47.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 7.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Oncology (abbr: CURR ONCOL, ISSN: 1198-0052) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Multimed Inc. in Canada since 1994. The periodical holds a Journal Impact Factor (JIF) of 3.60, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.132 (Q2), an H-index of 84.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 437 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,300 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.